Annual report pursuant to Section 13 and 15(d)

Accrued Expenses And Other Current Liabilities (Tables)

v3.20.1
Accrued Expenses And Other Current Liabilities (Tables)
12 Months Ended
Dec. 31, 2019
Accrued Liabilities and Other Liabilities [Abstract]  
Schedule of accrued expenses and other current liabilities
Accrued expenses and other current liabilities as of December 31, 2019 and 2018 consisted of the following:
 
 
 
December 31,
 
 
2019
 
2018
Sales returns and allowances
 
$
2,284,175

 
$
1,465,419

Medicaid rebates
 
118,271

 
50,246

Minimum sales commitments, royalties payable, and purchase obligations
 
75,000

 
8,954,521

Compensation and benefits
 
1,591,964

 
1,953,065

Research and development expenses
 
920,901

 
278,132

General and administrative
 
360,016

 
1,112,378

Sales and marketing
 
120,056

 
235,721

Other
 
169,869

 
279,397

Accrued expenses and other current liabilities
 
$
5,640,252

 
$
14,328,879